Phenoxybenzamine Hydrochloride Capsule shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting Dec 1, 2025 · last update Dec 1, 2025
Manufacturers: Advanz Pharma (US) Corp.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Dibenzyline, Capsule, 10 mg (NDC 59212-001-01) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 1, 2025 Updated Dec 1, 2025 Discontinued Dec 1, 2025 |
| Dibenzyline, Capsule, 10 mg (NDC 59212-001-02) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 1, 2025 Updated Dec 1, 2025 Discontinued Dec 1, 2025 |
| Dibenzyline, Capsule, 10 mg (NDC 66993-066-02) | Advanz Pharma (US) Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 1, 2025 Updated Dec 1, 2025 Discontinued Dec 1, 2025 |